In the context of ATI, the risk remains uncertain, but there is a hypothetical increased risk of severe COVID-19 outcomes for individuals with high HIV viral loads, and the associated immune activation and inflammation, or drop in CD4 T cell counts. This evidence concerns the gene CD4 and COVID-19.